研究業績一覧表
業績分類No.

論文題名1)原１

頭蓋外進展を伴った中頭蓋窩腫瘍に対する Supraorbito-zygomatic pterional
and infratemporal approach について／福島武雄、松田年浩、土持廣仁、中山義也、呉 義憲、継 仁、朝長正道、前原史明、大慈彌裕之－福岡大学医学紀要（1992,19(3):325-323）

2

An observation of the third ventricle under flexible fiberoptic
ventriculoscope: normal structure.／Oka K, Go Y, Kin Y, Tomonaga M.
－Surg Neurol. (1993Oct,40(4):273-277)

3

Plasminogen activator and hemorrhage in brain tumors.／Oka K, Tsuda
H, Sakamoto S, Go Y, Tomonaga M.－J Neurooncol. (1994,22(2):183-187)

著

456／

著者

－

発表雑誌（年、巻（号）：頁）

Obstruction of the superior sagittal sinus caused by parasagittal
meningiomas: the role of collateral venous pathways.／Oka K, Go Y,
Kimura H, Tomonaga M.－J Neurosurg. (1994 Oct,81(4):520-524)
Biological significance of tissue-type plasminogen activator,
urokinase-type plasmonogen activator, and plasmonogen activator
inhibitor type-1 within brain tumors／Oka,K.,Kin,Y.,Go,Y.,Sakamoto,S.,Kimura,H. and Tomonaga,M－Advances in Clinical Neurosciences (1995,5:269-280)
The radiographic restoration of the ventricular system after thirdventriculostomy.／Oka K, Go Y, Kin Y, Utsunomiya H, Tomonaga M－Minim Invasive Neurosurg. (1995 Dec,38(4):158-162)

7

Expression of cathepsin D during the progression of human gliomas.
／Sivaparvathi M, Sawaya R, Chintala SK, Go Y, Gokaslan ZL, Rao JS.
－Neurosci Lett(1996 Apr 26,208(3):171-174)

8

Role of extracellular matrix proteins in regulation of human glioma cell
invasion in vitro.／Chintala SK, Gokaslan ZL, Go Y, Sawaya R, Nicolson
GL, Rao JS.－Clin Exp Metastasis. (1996 Sep,14(4):358-366)

頁：1／4

業績分類No.

論文題名

9Hemorrhage from abdominal non-Hodgkin's lymphoma treatedsuccessfully by emergency transcatheter arterial embolization.／Suzumiya J, Nagano M, Higashihara H, Yoshida T, Hirano M, Go Y,Morioka E, Kimura N, Hisano S, Okazaki M, Kikuchi M, Okumura M.
－Am J Hematol.( 1996 Jul,52(3):201-204)

10／

著者

－

発表雑誌（年、巻（号）：頁）

Invasive pattern of lac-Z-transfected human glioblastoma cells in nude
mice brain.／Go Y, Chintala SK, Oka K, Gokaslan Z, Sawaya R, Rao JS.
－Cancer Lett. (1996 Dec 20,110(1-2):225-231)

11

In vitro inhibition of human glioblastoma cell line invasiveness byantisense uPA receptor／Mohanam,S.,Chintala,S.K. ,Go,Y.,
Bhattacharya,A.,Venkaiah,B.,Boyd,D.,Gokaslan,Z.L.,
Sawaya,R. and Rao,J.S.－Oncogene (1997 ,14:1351-1359)

12

Altered in vitro spreading and cytoskeletal organization in human glioma
cells by downregulation of urokinase receptor.／Chintala SK, Mohanam S,
Go Y, Venkaiah B, Sawaya R, Gokaslan ZL, Rao JS.－Mol Carcinog.
(1997Dec,20(4):355-365)

13

Cisplatin but not BCNU inhibits urokinase-type plasminogen activator
levels in human glioblastoma cell lines in vitro.／Go Y, Chintala SK,
Rayford A, Gagercas E, Ali-Osman F, Venkaiah B, Sawaya R, Gokaslan Z,
Nicolson GL, Rao JS.－Clin Exp Metastasis.(1997 Jul,15(4):447-452)

14

Inhibition of in vivo tumorigenicity and invasiveness of a humanglioblastoma cell line transfected with antisense uPAR vectors. ／Go Y,
Chintala SK, Mohanam S, Gokaslan Z, Venkaiah B, Bjerkvig R, Oka K,
Nicolson GL, Sawaya R, Rao JS. －Clin Exp Metastasis.
(1997 Jul,15(4):440-446)

15

Effect of cisplatin and BCNU on MMP-2 levels in human glioblastoma celllines in vitro.／Chintala SK, Ali-Osman F, Mohanam S, Rayford A, Go Y,Gokaslan ZL, Gagercas E, Venkaiah B, Sawaya R, Nicolson GL, Rao JS.
－Clin Exp Metastasis. (1997 Jul,15(4):361-367)

16

Elevated levels of Mr 92,000 type IV collagenase during tumor growth invivo.／Sawaya R, Go Y, Kyritisis AP, Uhm J, Venkaiah B, Mohanam S,Gokaslan ZL, Rao JS.－Biochem Biophys Res Commun.
(1998 Oct20,251(2):632-636)

17

Elevated levels of urokinase-type plasminogen activator and its receptor
during tumor growth in vivo.／Mohanam S, Go Y, Sawaya R, Venkaiah B,Mohan PM, Kouraklis GP, Gokaslan ZL, Lagos GK, Rao JS. －Int J Oncol.
(1999 Jan,14(1):169-174)
頁：2／4

業績分類

No.

論文題名

18

Neuroendoscopic approach to tectal tumors: a consecutive series.／Oka K,Kin Y, Go Y, , Hirakawa K, Tomonaga M, Inoue T, Yoshioka S.
－Neurosurgical Focus (1999,6(4):Article 14)

19

Meningioma:A histologic and immunohistochemical analysis with
MIB-1,PCNA,AgNOR and p53 for appraising the malignant potential inmeningioma／Go,Y.,Iwasaki,H.,Oka,K.,Ohjimi,Y.,Kikuchi,M.
and Tomonaga,M.－Medical Bulletin of Fukuoka University(1999,26(1):1-14)

20

Sequential Astrocytic Changes in Wound Healing Process of the Rat Brain／Hirakawa,T.,Oka,K.,Go,Y.,and Kimura,H.－Medical Bulletin ofFukuoka University (1999,26(2):49-57)

21

Neuroendoscopic approach to tectal tumors: a consecutive series.／Oka K,Kin Y, Go Y, Ueno Y, Hirakawa K, Tomonaga M, Inoue T, Yoshioka S. －J
Neurosurg.(1999 Dec,91(6):964-970)

22

／著者

－発表雑誌（年、巻（号）：頁）

Experience with an ultrasonic aspirator in neuroendoscopy.／Oka K, GoY, Yamamoto M, Kumate S, Tomonaga M. －Minim Invasive Neurosurg.
(1999 Mar,42(1):32-34)

23

A novel role for the urokinase-type plasminogen activator receptor inapotosis of malignant gliomas.／Kin Y, Chintala SK, Go Y, Sawaya R,Mohanam S, Kyritsis AP, Rao JS .－Int J Oncol. (2000 Jul,17(1):61-65)

24

Endovascular treatment of anterior cerebral artery aneurysms usingGuglielmi detachable coils: mid-term clinical evaluation／Kazekawa K,Tsutsumi M, Aikawa H, Iko M, Tanaka A, Go Y, Kawano H.－Radiat Med.
(2002 Nov-Dec,20(6):291-297)

25

Dural AVFs of the cavernous sinus: transvenous embolization using a
direct superficial temporal vein approach. ／ Kazekawa K, Iko M,
Sakamoto S, Aikawa H, Tsutsumi M, Kodama T, Go Y, Tanaka A.－RadiatMed.(2003 May-Jun,21(3):138-141)

26

Internal carotid aneurysms presenting with mass effect symptoms ofcranial nerve dysfunction: efficacy and imitations of endosaccularembolization with GDC.／Kazekawa K, Tsutsumi M, Aikawa H, Iko M,
Kodama T, Go Y, Tanaka A.－Radiat Med.(2003 Mar-Apr,21(2):80-85)

27

Hemodynamic stability under general anesthesia in carotid arterystenting.／Nagata S, Kazekawa K, Aikawa H, Tsutsumi M, Kodama T,Iko M, Nii K, Matsubara S, Go Y, Tanaka A. － Radiat Med.(2005
Sep,23(6):427-431)
頁：3／4

業績分類

No.

論文題名

28

Direct carotid puncture for the endovascular treatment of anterior
circulation aneurysms. ／ Nii K, Kazekawa K, Onizuka M, Aikawa H,Tsutsumi M, Tomokiyo M, Iko M, Kodama T, Matsubara S, Go Y, Tanaka
A.－AJNR Am J Neuroradiol. (2006 Aug,27(7):1502-1504)

2930

31323334／

著者－発表雑誌（年、巻（号）：頁）

Spontaneous improvement of persistent ulceration after carotid arterystenting.／Kohyama S, Kazekawa K, Iko M, Aikawa H, Tsutsumi M, GoY, Nagata S, Kodama T, Nii K, Matsubara S, Tanaka A.－AJNR Am J
Neuroradiol. (2006 Jan,27(1):151-156)
Clinical efficacy of blood flow interruption using the HyperForm in rightvertebral arteriovenous fistula-case report／Nii K, Kazekawa K, AikawaH, Onizuka M, Tsutsumi M, Iko M, Kodama T, Matsubara S, Etou H, GoY, Tanaka A.－Brain Nerve. (2007 Aug,59(8):887-890. Japanese.)
Shortening of Wallstent RP during carotid artery stenting requires
appropriate stent placement. ／ Aikawa H, Nagata S, Onizuka M,Tsutsumi M, Iko M, Kodama T, Nii K, Matsubara S,Etou H, Go Y,Kazekawa K. － Neurol Med Chir (Tokyo). (2008 Jun,48(6):249-252;
discussion 252-253)
Carotid artery stenting in a patient with internal carotid artery stenosis
and ipsilateral persistent primitive hypoglossal artery presenting withtransient ischemia of the vertebrobasilar system: case report.／Nii K1,Aikawa H, Tsutsumi M, Onizuka M, Nakau H, Inoue R, Go Y, Kazekawa
K.－Neurol Med Chir (Tokyo). (2010;50(10):921-4.)
Distal protection filter device efficacy with carotid artery stenting:comparison between a distal protection filter and a distal protection
balloon.／Iko M, Tsutsumi M, Aikawa H, Matsumoto Y, Go Y, Nii K, Abe G,
Ye I, Nomoto Y, Kazekawa K.－ Jpn J Radiol. (2013 Jan,31(1):45-9. doi:
10.1007/s11604-012-0145-9. Epub 2012 Nov 20.)
Treatment outcomes of carotid artery stenting with two types of distal
protection filter device.／Iko M1, Aikawa H1, Go Y1, Nakai K1, Tsutsumi
M1, Yu I1, Mizokami T1, Sakamoto K1, Inoue R1, Mitsutake T1, Eto A1,Hanada H1, Kazekawa K1.－Springerplus. (2014 Mar 8;3:132. doi:10.1186/2193-1801-3-132. eCollection 2014.)

頁：4／4